Skip to content
yes i take peptides · shopping companion

FOXO4-DRI

Category · For LongStatus · RUOCitations · 17One-paper compound
The verdict

No — and this is one of the few peptides on this site we'd actively recommend against.

By source — cost, legality, risk
  • Brand
    Not available
    None — no FDA approval; no clinical-stage development
    No FDA-approved FOXO4-DRI exists.
  • Compounded 503A pharmacy
    $400–$800/mo where sold
    Off-label · cytotoxic mechanism, most compounders decline
    High. Compounders shipping a deliberately-cytotoxic peptide pre-trial are legally and ethically exposed.
  • RUO research peptide
    $150–$400/mo
    Sold 'for research only'
    Highest. D-retro-inverso synthesis is hard, sub-90% purity is common; identity by mass spec alone is insufficient.
  • Gray-market raw
    ~$38/mo
    Unregulated overseas import
    Crypto/Wise pay; D-retro-inverso stereochemistry verification is even harder for gray vendors than for RUO.
Stop signals · abort if
  • persistent fevers > 48 hours
  • new bruising or bleeding
  • jaundice or RUQ pain
  • chest pain or shortness of breath
  • any new mass or unexplained pain
  • severe or worsening "flu-like" reaction
Sources · top 5 of 17
  1. 01Born E, et al. Eliminating Senescent Cells Can Promote Pulmonary Hypertension Development and Progression. Circulation. 2023;147(8):650-666. PMID: 36515093.
  2. 02Liu Y, et al. FOXO4-D-Retro-Inverso targets extracellular matrix production in fibroblasts and ameliorates bleomycin-induced pulmonary fibrosis in mice. Naunyn-Schmiedeberg's archives of pharmacology. 2023;396(10):2393-2403. PMID: 37074394.
  3. 03Meng J, et al. Targeting senescence-like fibroblasts radiosensitizes non-small cell lung cancer and reduces radiation-induced pulmonary fibrosis. JCI insight. 2021;6(23). PMID: 34877934.
  4. 04Bourgeois B, et al. The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI. Nature communications. 2025;16(1):5672. PMID: 40593617.
  5. 05Kong YX, et al. FOXO4-DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53-serine 15 phosphorylation. Communications biology. 2025;8(1):299. PMID: 39994346.
⚠ Not medical advice

We are not your doctor. Consult a licensed clinician before injecting any peptide. Verify every dose, vial size, and unit count against your vendor’s Certificate of Analysis before drawing.

Printed Jun 15, 2026 · yesitakepeptides.com/peptides/foxo4-dri